4.4 Article

Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis

Journal

FRONTIERS IN SURGERY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fsurg.2022.928452

Keywords

hepatocellular carcinoma; portal vein tumor thrombosis; combining liver partition and portal vein ligation after thrombectomy for tumor isolation; associating liver partition and portal vein ligation for staged hepatectomy; future liver remnant

Categories

Funding

  1. National Natural Science Foundation of China [81560387, 81902983]
  2. Guangxi Natural Science Foundation of China [2018JJB140382]
  3. Medical Excellence Award - Creative Research Development grant from the First Affiliated Hospital of Guangxi Medical University [180327]
  4. Guangxi Medical and Health Technology Development application project [S2019097, S2018100]
  5. Emergency and Medical Rescue Talent Small Highland in Guangxi Zhuang Autonomous Region.Open Topics of Key Laboratory for Emergency Medicine in Guangxi Universities [GXJZ201501]
  6. Project to Improve the Basic Research Ability of Young and Middle-aged Teachers in Guangxi Universities [2019KY0123]
  7. Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer
  8. Self-Raised Project of Guangxi Health Committee [Z-A20220492]

Ask authors/readers for more resources

The study retrospectively analyzed three cases of advanced HCC with PVTT and proposed a new surgical option. The surgical procedure involved portal vein thrombectomy and liver parenchymal separation, followed by targeted drug treatment postoperatively. The results showed favorable prognosis and significantly prolonged survival time for the three patients.
Background: Primary liver cancer is the third leading cause of cancer-related deaths worldwide in 2020, and hepatocellular carcinoma (HCC) is the major pathological type. Patients with HCC complicated with portal vein tumor thrombosis (PVTT) have a poor prognosis, and controversies regarding treatment options exist among international scholars. Patients with VP4 or Cheng's type III classification are generally considered ineligible for surgical treatment. Methods: We retrospectively analyzed three cases of HCC with PVTT who underwent a novel modified surgical procedure. The procedure included portal vein thrombectomy and portal vein ligation with liver parenchymal separation for the resection of the tumor thrombus involving the main portal vein trunk and for the isolation of the giant tumor. The three cases were then treated with targeted drugs postoperatively. Results: One case developed acute renal failure in the perioperative period, and the renal function gradually recovered after the treatment. The two remaining cases recovered uneventfully postoperatively. The prognosis of the three patients was encouraging. Only one patient died of lung metastasis after 13 months, and the remaining patients were still alive after 41 and 21 months, respectively. Conclusions: We provide a new possible surgical option for patients with advanced HCC with PVTT. The surgical procedure was inspired by associating liver partition with portal vein ligation for staged hepatectomy and portal vein thrombectomy. The survival time was significantly prolonged after the patients underwent thrombectomy, tumor isolation, and postoperative nonsurgical treatment. Hence, the combination of liver partition and portal vein ligation after thrombectomy for tumor isolation has the potential for the treatment of advanced HCC with PVTT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available